Adjuvance Technologies Revenue, Growth & Competitor Profile

DBA ADJUVANCE
DBA ADJUVANCE TECHNOGIES INC.

Company Profile & Annual Report for Adjuvance Technologies

Access the complete profile.

Adjuvance Technologies Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	1225 L St Ste 600 Lincoln, NE 68508

Note: Revenues for privately held companies are statistical evaluations.


Adjuvance Technologies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Adjuvance Technologies's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Adjuvance Technologies is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Adjuvance Technologies Annual Revenue and Growth Rate

Adjuvance Technologies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Adjuvance Technologies's revenues are gauged from an analysis of company filings.

Adjuvance Technologies's Income Statement (based on Industry Averages)

Adjuvance Technologies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Adjuvance Technologies is developing and marketing. Adjuvance Technologies doesn't have any recent trademark applications, indicating Adjuvance Technologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SAPONEX Adjuvants for use with vaccines; Vaccine adjuvants; Vaccines	06/27/2013
ADJUVANCE Adjuvants for medical purposes; Adjuvants for use with vaccines; Vaccine adjuvants	06/27/2013
TITERQUIL Adjuvants for medical purposes; Adjuvants for use with vaccines; Vaccine adjuvants	06/27/2013

See all trademarks and details in the Full Report.

Market Share of Adjuvance Technologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Adjuvance Technologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Adjuvance Technologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CELERION	Lincoln, NE	100
ADJUVANCE TECHNOLOGIES	Lincoln, NE	2
BE WELL CLINICAL STUDIES	Lincoln, NE	2
NATURE TECHNOLOGY	Lincoln, NE	1
OCUVERA	Lincoln, NE	1
FARMAFIELD LABS	Lincoln, NE	1

Future Competition: Adjuvance Technologies's Fastest Growing Competitors

These companies are in the same general field as Adjuvance Technologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)